149 related articles for article (PubMed ID: 30838647)
1. Adjuvant chemotherapy and outcomes in patients with nodal and resection margin-negative pancreatic ductal adenocarcinoma: A systematic review and meta-analysis.
Flaum N; Hubner RA; Valle JW; Amir E; McNamara MG
J Surg Oncol; 2019 Jun; 119(7):932-940. PubMed ID: 30838647
[TBL] [Abstract][Full Text] [Related]
2. The Impact of Positive Resection Margins on Survival and Recurrence Following Resection and Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma.
Ghaneh P; Kleeff J; Halloran CM; Raraty M; Jackson R; Melling J; Jones O; Palmer DH; Cox TF; Smith CJ; O'Reilly DA; Izbicki JR; Scarfe AG; Valle JW; McDonald AC; Carter R; Tebbutt NC; Goldstein D; Padbury R; Shannon J; Dervenis C; Glimelius B; Deakin M; Anthoney A; Lerch MM; Mayerle J; Oláh A; Rawcliffe CL; Campbell F; Strobel O; Büchler MW; Neoptolemos JP;
Ann Surg; 2019 Mar; 269(3):520-529. PubMed ID: 29068800
[TBL] [Abstract][Full Text] [Related]
3. Contemporary Reappraisal of Intraoperative Neck Margin Assessment During Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma: A Review.
Datta J; Willobee BA; Ryon EL; Shah MM; Drebin JA; Kooby DA; Merchant NB
JAMA Surg; 2021 May; 156(5):489-495. PubMed ID: 33533898
[TBL] [Abstract][Full Text] [Related]
4. Does revision of resection margins based on frozen section improve overall survival following pancreatoduodenectomy for pancreatic ductal adenocarcinoma? A meta-analysis.
Barreto SG; Pandanaboyana S; Ironside N; Windsor JA
HPB (Oxford); 2017 Jul; 19(7):573-579. PubMed ID: 28420560
[TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of para-aortic lymph node metastasis in pancreatic ductal adenocarcinoma.
Murakami Y; Uemura K; Sudo T; Hashimoto Y; Yuasa Y; Sueda T
World J Surg; 2010 Aug; 34(8):1900-7. PubMed ID: 20376442
[TBL] [Abstract][Full Text] [Related]
6. Intraoperative Pancreatic Neck Margin Assessment During Pancreaticoduodenectomy for Pancreatic Adenocarcinoma in the Era of Neoadjuvant Therapy: A Multi-institutional Analysis from the Central Pancreatic Consortium.
Kelly KN; Macedo FI; Seaton M; Wilson G; Hammill C; Martin RC; Maduekwe UN; Kim HJ; Maithel SK; Abbott DE; Ahmad SA; Kooby DA; Merchant NB; Datta J
Ann Surg Oncol; 2022 Sep; 29(9):6004-6012. PubMed ID: 35511392
[TBL] [Abstract][Full Text] [Related]
7. Improved survival after pancreatic re-resection of positive neck margin in pancreatic cancer patients. A systematic review and network meta-analysis.
Crippa S; Ricci C; Guarneri G; Ingaldi C; Gasparini G; Partelli S; Casadei R; Falconi M
Eur J Surg Oncol; 2021 Jun; 47(6):1258-1266. PubMed ID: 33487492
[TBL] [Abstract][Full Text] [Related]
8. Oncologic outcomes of minimally invasive versus open distal pancreatectomy for pancreatic ductal adenocarcinoma: A systematic review and meta-analysis.
van Hilst J; Korrel M; de Rooij T; Lof S; Busch OR; Groot Koerkamp B; Kooby DA; van Dieren S; Abu Hilal M; Besselink MG;
Eur J Surg Oncol; 2019 May; 45(5):719-727. PubMed ID: 30579652
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant Chemotherapy Associated with Survival Benefit Following Neoadjuvant Chemotherapy and Pancreatectomy for Pancreatic Ductal Adenocarcinoma: A Population-Based Cohort Study.
Kamarajah SK; White SA; Naffouje SA; Salti GI; Dahdaleh F
Ann Surg Oncol; 2021 Oct; 28(11):6790-6802. PubMed ID: 33786676
[TBL] [Abstract][Full Text] [Related]
10. History of preoperative therapy for pancreatic cancer and the MD Anderson experience.
Gaskill CE; Maxwell J; Ikoma N; Kim MP; Tzeng CW; Lee JE; Katz MHG
J Surg Oncol; 2021 May; 123(6):1414-1422. PubMed ID: 33831256
[TBL] [Abstract][Full Text] [Related]
11. Influence of resection margins and treatment on survival in patients with pancreatic cancer: meta-analysis of randomized controlled trials.
Butturini G; Stocken DD; Wente MN; Jeekel H; Klinkenbijl JH; Bakkevold KE; Takada T; Amano H; Dervenis C; Bassi C; Büchler MW; Neoptolemos JP;
Arch Surg; 2008 Jan; 143(1):75-83; discussion 83. PubMed ID: 18209156
[TBL] [Abstract][Full Text] [Related]
12. A systematic review and network meta-analysis of phase III randomised controlled trials for adjuvant therapy following resection of pancreatic ductal adenocarcinoma (PDAC).
Kamarajah SK; Bundred JR; Alrawashdeh W; Manas D; White SA
HPB (Oxford); 2020 May; 22(5):649-659. PubMed ID: 31894014
[TBL] [Abstract][Full Text] [Related]
13. Positive para-aortic lymph nodes following pancreatectomy for pancreatic cancer. Systematic review and meta-analysis of impact on short term survival and association with clinicopathologic features.
Agalianos C; Gouvas N; Papaparaskeva K; Dervenis C
HPB (Oxford); 2016 Aug; 18(8):633-41. PubMed ID: 27485057
[TBL] [Abstract][Full Text] [Related]
14. Which is the optimal adjuvant chemotherapy for resected pancreatic ductal adenocarcinoma?: A protocol for a network meta-analysis of randomized controlled trials.
Hu Q; Wang X; Chen Y; Li X; Cao P; Cao D
Medicine (Baltimore); 2019 May; 98(21):e15761. PubMed ID: 31124963
[TBL] [Abstract][Full Text] [Related]
15. Improvement of survival after surgical resection of pancreatic cancer independent of adjuvant chemotherapy in the past two decades - A meta-regression.
Weniger M; Miksch RC; Maisonneuve P; Werner J; D'Haese JG
Eur J Surg Oncol; 2020 Aug; 46(8):1516-1523. PubMed ID: 32204936
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant chemotherapy in elderly patients with pancreatic cancer.
Nagrial AM; Chang DK; Nguyen NQ; Johns AL; Chantrill LA; Humphris JL; Chin VT; Samra JS; Gill AJ; Pajic M; ; Pinese M; Colvin EK; Scarlett CJ; Chou A; Kench JG; Sutherland RL; Horvath LG; Biankin AV
Br J Cancer; 2014 Jan; 110(2):313-9. PubMed ID: 24263063
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic resection for M1 pancreatic ductal adenocarcinoma.
Shrikhande SV; Kleeff J; Reiser C; Weitz J; Hinz U; Esposito I; Schmidt J; Friess H; Büchler MW
Ann Surg Oncol; 2007 Jan; 14(1):118-27. PubMed ID: 17066229
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Value of Resection Margin Involvement After Pancreaticoduodenectomy for Ductal Adenocarcinoma: Updates From a French Prospective Multicenter Study.
Delpero JR; Jeune F; Bachellier P; Regenet N; Le Treut YP; Paye F; Carrere N; Sauvanet A; Adham M; Autret A; Poizat F; Turrini O; Boher JM
Ann Surg; 2017 Nov; 266(5):787-796. PubMed ID: 28953554
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of positive histological margins in patients with pancreatic head ductal adenocarcinoma and lymph node involvement: an international multicentric study.
Joliat GR; Allemann P; Labgaa I; Sulzer J; Vrochides D; Zerbi A; Nappo G; Perinel J; Adham M; Nentwich MF; Izbicki JR; Demartines N; Schäfer M
HPB (Oxford); 2021 Mar; 23(3):379-386. PubMed ID: 32782224
[TBL] [Abstract][Full Text] [Related]
20. Review of adjuvant radiochemotherapy for resected pancreatic cancer and results from Mayo Clinic for the 5th JUCTS symposium.
Miller RC; Iott MJ; Corsini MM
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):364-8. PubMed ID: 19735864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
